Stroke, Vol 24, 1043-1047, Copyright © 1993 by American Heart Association
WI Rosenblum, T Shimizu and GH Nelson
BACKGROUND AND PURPOSE: The effects of substance P (SP) and calcitonin
gene-related peptide (CGRP) were tested on pial arterioles of mice. This
was done because (1) perivascular peptidergic nerves may play an important
role in modulation of cerebrovascular responses; (2) there are conflicting
data concerning the mechanism of action of CGRP; (3) there are few or no
studies directly testing the endothelium dependence of dilation by these
peptides in the cerebral circulation; and (4) we wished to extend previous
observations of mice by comparing peptidergic responses in the mouse with
those published for other species. METHODS: The pial arterioles were
monitored in vivo using video microscopy and image-shearing techniques for
measuring diameter. Focal endothelial injury was produced with a
laser-Evans blue technique. Responses to SP and CGRP were tested before and
after endothelial injury. They were also tested before and during treatment
with agents that interfere with responses mediated by endothelium-derived
relaxing factor (EDRFACh). They were also tested before and during
treatment with indomethacin. RESULTS: Both CGRP and SP produced dilation
that was blocked by endothelial injury and by agents interfering with
responses mediated by EDRFACh. Indomethacin had no effect. CONCLUSIONS: SP
and CGRP produce endothelium-dependent dilations. These dilations are
probably mediated by EDRFACh. With respect to SP, these results are similar
to those reported for other vessels and species. With respect to CGRP, the
finding of endothelium dependence has not been previously reported for
cerebral vessels. However, very few species have been tested. Reports of
other vascular beds in other species sometimes parallel and sometimes
contradict our findings with CGRP.
ARTICLES
Endothelium-dependent effects of substance P and calcitonin gene- related peptide on mouse pial arterioles
Department of Pathology (Neuropathology), Virginia Commonwealth University-Medical College of Virginia, Richmond.
This article has been cited by other articles:
![]() |
K. Hosaka, S. E. Rayner, P.-Y. von der Weid, J. Zhao, M. S. Imtiaz, and D. F. van Helden Calcitonin gene-related peptide activates different signaling pathways in mesenteric lymphatics of guinea pigs Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H813 - H822. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Najarian, A. M. Marrache, I. Dumont, P. Hardy, M. H. Beauchamp, X. Hou, K. Peri, F. Gobeil Jr, D. R. Varma, and S. Chemtob Prolonged Hypercapnia-Evoked Cerebral Hyperemia via K+ Channel- and Prostaglandin E2-Dependent Endothelial Nitric Oxide Synthase Induction Circ. Res., December 8, 2000; 87(12): 1149 - 1156. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Pedersen, C. K. Buckner, S. N. Meeker, and B. J. Undem Pharmacological Examination of the Neurokinin-1 Receptor Mediating Relaxation of Human Intralobar Pulmonary Artery J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 319 - 325. [Abstract] [Full Text] |
||||
![]() |
I. Dumont, X. Hou, P. Hardy, K. G. Peri, M. Beauchamp, T. Najarian, S. Molotchnikoff, D. R. Varma, and S. Chemtob Developmental Regulation of Endothelial Nitric Oxide Synthase in Cerebral Vessels of Newborn Pig by Prostaglandin E2 J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 627 - 633. [Abstract] [Full Text] |
||||
![]() |
W. G. Mayhan and K. P. Patel Treatment with dimethylthiourea prevents impaired dilatation of the basilar artery during diabetes mellitus Am J Physiol Heart Circ Physiol, June 1, 1998; 274(6): H1895 - H1901. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. FARACI and D. D. HEISTAD Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels Physiol Rev, January 1, 1998; 78(1): 53 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hirata, H. Hayakawa, Y. Suzuki, E. Suzuki, H. Ikenouchi, O. Kohmoto, K. Kimura, K. Kitamura, T. Eto, K. Kangawa, et al. Mechanisms of Adrenomedullin-Induced Vasodilation in the Rat Kidney Hypertension, April 1, 1995; 25(4): 790 - 795. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |